|
The 2024 U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR) addresses a selected group of common, but sometimes complex, issues regarding initiation and use of specific contraceptive methods.
These recommendations for health care providers were updated by the Centers for the Disease Control and Prevention (CDC) after review of the scientific evidence and a meeting with national experts in Atlanta, Georgia, during January 25–27, 2023.
The information in this report replaces the 2016 U.S. SPR (CDC. U.S. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR 2016;65[No. RR-4]:1–66).
Notable updates
- Updated recommendations for provision of medications for intrauterine device placement.
- Updated recommendations for bleeding irregularities during implant use.
- New recommendations for testosterone use and risk for pregnancy.
- New recommendations for self-administration of injectable contraception.
The recommendations in this report are intended to serve as a source of evidence-based clinical practice guidance for health care providers. The goals of these recommendations are to remove unnecessary medical barriers to accessing and using contraception and to support the provision of person-centered contraceptive counseling and services in a noncoercive manner. Health care providers should always consider the individual clinical circumstances of each person seeking contraceptive services.
This report is not intended to be a substitute for professional medical advice for individual patients; when needed, patients should seek advice from their health care providers about contraceptive use.
|
